The triglyceride-glucose (TyG) index, which has superiority in assessing IR in both patients with and without diabetes and applicability to all subjects regardless of their status as recipients of insulin treatment, was created to get over this limitation [7, 8]. This evidence concerns the gene INS and diabetes mellitus.